secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-10-07T13:00:14+00:00
Accession:  0001213900-26-107434
Event type: litigation
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Envoy Medical settles Atlas SPAC redemption suit; all claims dismissed with prejudice, no payment owed
--------------------------------------------------------------------------------

- Envoy Medical entered a Dismissal Agreement on October 6, 2026 ending Delaware Court of Chancery litigation brought by Atlas Merchant Capital SPAC Fund I LP.
- Atlas had alleged it was not allowed to redeem its Class A Common Stock in the Company's September 2023 business combination transaction.
- All of Atlas' claims will be dismissed with prejudice and no further proceedings will occur in the Litigation.
- Neither Envoy Medical nor any other defendant is required to make any payment to Atlas under the Dismissal Agreement.
- 8-K signed October 7, 2026 by CEO Brent Lucas; Exhibit 104 cover page XBRL only, no financial statements filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026107434/0001213900-26-107434-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026107434/ea0307906-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-107434

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer